Abstract
Diabetic patients are more susceptible to cardiovascular diseases than nondiabetic patients. In addition, cardiovascular diseases associated with diabetes are a major cause of mortality and morbidity among diabetic people in the world. Diabetes has alarmingly continued to affect human beings around the world, and still continues especially in developed or developing countries with an increasing pace. There is a growing need for innovative and effective therapies for the management of hyperglycemia and the improvement of cardiovascular complications in diabetic patients as well. Herein, herbal medicine or products play an essential role in developing a new cure or improving the efficiency of the antidiabetic drugs with the features of cardioprotective effects. This chapter highlights some promising herbal remedies, including resveratrol, berberine, ginseng, curcumin, and ginkgo in the therapeutic usage for controlling of hyperglycemia as well as in either preventing or decreasing the susceptibility of diabetic patients to cardiovascular diseases with a focus on possible underlying mechanisms of their effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel Aziz MT, El-Asmar MF, El-Ibrashy IN, Rezq AM, Al-Malki AL, Wassef MA, Fouad HH, Ahmed HH, Taha FM, Hassouna AA, Morsi HM (2012) Effect of novel water soluble curcumin derivative on experimental type-1 diabetes mellitus (short term study). Diabetol Metab Syndr 4:30
Abo-Salem OM, Harisa GI, Ali TM, El-Sayed El SM, Abou-Elnour FM (2014) Curcumin ameliorates streptozotocin-induced heart injury in rats. J Biochem Mol Toxicol 28:263â270
American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62âS69
Amin KA, Awad EM, Nagy MA (2011) Effects of Panax quinquefolium on streptozotocin-induced diabetic rats: role of C-peptide, nitric oxide and oxidative stress. Int J Clin Exp Med 4:136â147
Anupunpisit V, Petpiboolthai H, Khimmaktong W (2015) Microvasculature improvement of heart in diabetic rat with curcumin supplementation. J Med Assoc Thail 98(Suppl 10):S74âS83
Arârajab A, Ahren B (1993) Long-term diabetogenic effect of streptozotocin in rats. Pancreas 8:50â57
Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, Turkoz Y, Yologlu S (2007) Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci 14:256â260
Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69â82
Aziz MT, El Ibrashy IN, Mikhailidis DP, Rezq AM, Wassef MA, Fouad HH, Ahmed HH, Sabry DA, Shawky HM, Hussein RE (2013) Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy. Diabetol Metab Syndr 5:13
Aziz MT, El-Asmar MF, Rezq AM, Wassef MA, Fouad H, Roshdy NK, Ahmed HH, Rashed LA, Sabry D, Taha FM, Hassouna A (2014) Effects of a novel curcumin derivative on insulin synthesis and secretion in streptozotocin-treated rat pancreatic islets in vitro. Chin Med 9:3
Baeg IH, So SH (2013) The world ginseng market and the ginseng (Korea). J Ginseng Res 37:1â7
Bagul PK, Dinda AK, Banerjee SK (2015) Effect of resveratrol on sirtuins expression and cardiac complications in diabetes. Biochem Biophys Res Commun 468:221â227
Balakumar P, Sharma NK (2012) Healing the diabetic heart: does myocardial preconditioning work? Cell Signal 24:53â59
Balakumar P, Maung UK, Jagadeesh G (2016) Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res 113:600â609
Bhatt LK, Veeranjaneyulu A (2014) Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes. Arch Med Res 45:203â209
Bhatt JK, Thomas S, Nanjan MJ (2012) Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 32:537â541
Blade C, Baselga-Escudero L, Arola-Arnal A (2014) microRNAs as new targets of dietary polyphenols. Curr Pharm Biotechnol 15:343â351
Bo S, Ponzo V, Ciccone G, Evangelista A, Saba F, Goitre I, Procopio M, Pagano GF, Cassader M, Gambino R (2016) Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. Pharmacol Res 111:896â905
Bonnefont-Rousselot D (2016) Resveratrol and cardiovascular diseases. Nutrients 8. https://doi.org/10.3390/nu8050250
Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B, Cseh J, Mikolas E, Szijarto IA, Merei A, Halmai R, Meszaros LG, Sumegi B, Wittmann I (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106:383â389
Brindisi MC, Bouillet B, Verges B, Halimi S (2010) Cardiovascular complications in type 1 diabetes mellitus. Diabetes Metab 36:341â344
Carolo Dos Santos K, Pereira Braga C, Octavio Barbanera P, Seiva FR, Fernandes Junior A, Fernandes AA (2014) Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol. PLoS One 9:e102775
Chan LS, Yue PY, Mak NK, Wong RN (2009) Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 38:370â377
Chang W (2017) Non-coding RNAs and berberine: a new mechanism of its anti-diabetic activities. Eur J Pharmacol 795:8â12
Chang W, Zhang M, Meng Z, Yu Y, Yao F, Hatch GM, Chen L (2015) Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5â²-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. Eur J Pharmacol 769:55â63
Chang W, Li K, Guan F, Yao F, Yu Y, Zhang M, Hatch GM, Chen L (2016) Berberine pretreatment confers cardioprotection against ischemia-reperfusion injury in a rat model of type 2 diabetes. J Cardiovasc Pharmacol Ther 21:486â494
Chen ZC, Cheng YZ, Chen LJ, Cheng KC, Li Y, Cheng J (2012) Increase of ATP-sensitive potassium (K(ATP)) channels in the heart of type-1 diabetic rats. Cardiovasc Diabetol 11:8
Chen K, Li G, Geng F, Zhang Z, Li J, Yang M, Dong L, Gao F (2014) Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats. Apoptosis 19:946â957
Chen R, Peng X, Du W, Wu Y, Huang B, Xue L, Wu Q, Qiu H, Jiang Q (2015) Curcumin attenuates cardiomyocyte hypertrophy induced by high glucose and insulin via the PPAR-gamma/Akt/NO signaling pathway. Diabetes Res Clin Pract 108:235â242
Cheng D, Liang B, Li Y (2013) Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. Biomed Res Int 2013:162724
Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, Su MJ (2007) Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci 80:1713â1720
Chueh WH, Lin JY (2011) Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. J Agric Food Chem 59:8021â8027
Chueh WH, Lin JY (2012a) Berberine, an isoquinoline alkaloid, inhibits streptozotocin-induced apoptosis in mouse pancreatic islets through down-regulating Bax/Bcl-2 gene expression ratio. Food Chem 132:252â260
Chueh WH, Lin JY (2012b) Protective effect of berberine on serum glucose levels in non-obese diabetic mice. Int Immunopharmacol 12:534â538
Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S (2012) Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35:2121â2127
Costantino S, Paneni F, Luscher TF, Cosentino F (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37:572â576
Dai P, Wang J, Lin L, Zhang Y, Wang Z (2015) Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: evaluation via biochemical markers and color Doppler ultrasonography. Exp Ther Med 10:869â876
Dai D, Zhang CF, Williams S, Yuan CS, Wang CZ (2017) Ginseng on cancer: potential role in modulating inflammation-mediated angiogenesis. Am J Chin Med 45:13â22
Defeudis FV (2003) A brief history of EGb 761 and its therapeutic uses. Pharmacopsychiatry 36(Suppl 1):S2âS7
Dong SF, Hong Y, Liu M, Hao YZ, Yu HS, Liu Y, Sun JN (2011) Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats. Eur J Pharmacol 660:368â374
Dong H, Wang N, Zhao L, Lu F (2012) Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med 2012:591654
Dziwenka M, Coppock RW (2016) Ginkgo biloba. In: Nutraceuticals: efficacy, safety and toxicity. Elsevier, Amsterdam, pp 681â691
El-Bahr SM (2013) Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats. BMC Complement Altern Med 13:368
El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SF, Ahmed AF (2011) The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-alpha and free fatty acids. Food Chem Toxicol 49:1129â1140
Fan Y, Liu L, Fang K, Huang T, Wan L, Liu Y, Zhang S, Yan D, Li G, Gao Y, Lv Y, Chen Y, Tu Y (2016) Resveratrol ameliorates cardiac hypertrophy by Down-regulation of miR-155 through activation of breast cancer type 1 susceptibility protein. J Am Heart Assoc 5:e002648
Fancher IS, Dick GM, Hollander JM (2013) Diabetes mellitus reduces the function and expression of ATP-dependent K(+) channels in cardiac mitochondria. Life Sci 92:664â668
Fitzl G, Welt K, Martin R, Dettmer D, Hermsdorf T, Clemens N, Konig S (2000) The influence of hypoxia on the myocardium of experimentally diabetic rats with and without protection by Ginkgo biloba extract I. Ultrastructural and biochemical investigations on cardiomyocytes. Exp Toxicol Pathol 52:419â430
Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137â188
Frendo-Cumbo S, Macpherson RE, Wright DC (2016) Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance. Physiol Rep 4:e12877
Gao Y, Kang L, Li C, Wang X, Sun C, Li Q, Liu R, Wang J (2016) Resveratrol ameliorates diabetes-induced cardiac dysfunction through AT1R-ERK/p38 MAPK signaling pathway. Cardiovasc Toxicol 16:130â137
Gencoglu H, Tuzcu M, Hayirli A, Sahin K (2015) Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Int J Food Sci Nutr 66:314â320
Gilmartin AB, Ural SH, Repke JT (2008) Gestational diabetes mellitus. Rev Obstet Gynecol 1:129â134
Gu Y, Zhang Y, Shi X, Li X, Hong J, Chen J, Gu W, Lu X, Xu G, Ning G (2010) Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 81:766â772
Gui QF, Xu ZR, Xu KY, Yang YM (2016a) The efficacy of ginseng-related therapies in type 2 diabetes mellitus. Medicine (United States) 95:e2584
Gui QF, Xu ZR, Xu KY, Yang YM (2016b) The efficacy of ginseng-related therapies in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Medicine (Baltimore) 95:e2584
Guo S, Yao Q, Ke Z, Chen H, Wu J, Liu C (2015) Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol Cell Endocrinol 412:85â94
Gupta SC, Patchva S, Koh W, Aggarwal BB (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39:283â299
Hayat SA, Patel B, Khattar RS, Malik RA (2004) Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107:539â557
Hosseini SA, Alipour M, Ghadiry A, Zakerkish M (2016) The effects of standardized extract of ginseng (G115) on blood sugar control and inflammatory factors in patients with type 2 diabetes: a double-blind clinical trial. Int J Pharm Res Allied Sci 5:55â59
Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, Haque R (2013) Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol Vis 19:544â560
Huang JP, Huang SS, Deng JY, Chang CC, Day YJ, Hung LM (2010) Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. Free Radic Biol Med 49:1710â1721
IDF (2016) Diabetes and cardiovascular disease. International Diabetes Federation, Brussels, Belgium
Ilyas EI, Nur BM, Laksono SP, Bahtiar A, Estuningtyas A, Vitasyana C, Kusmana D, Suyatna FD, Tadjudin MK, Freisleben HJ (2016) Effects of curcumin on parameters of myocardial oxidative stress and of mitochondrial glutathione turnover in Reoxygenation after 60 minutes of hypoxia in isolated perfused working Guinea pig hearts. Adv Pharmacol Sci 2016:6173648
Isah T (2015) Rethinking Ginkgo biloba L.: medicinal uses and conservation. Pharmacogn Rev 9:140â148
Jacobs BP, Browner WS (2000) Ginkgo biloba: a living fossil. Am J Med 108:341â342
Jin Y, Khadka DB, Cho WJ (2016) Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat 26:229â243
Jung CH, Seog HM, Choi IW, Choi HD, Cho HY (2005) Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. J Ethnopharmacol 98:245â250
Karaca T, Yoruk M, Yoruk IH, Uslu S (2010) Effects of extract of green tea and ginseng on pancreatic beta cells and levels of serum glucose, insulin, cholesterol and triglycerides in rats with experimentally streptozotocin-induced diabetes: a histochemical and immunohistochemical study. J Anim Vet Adv 9:102â107
Karuppagounder V, Arumugam S, Giridharan VV, Sreedhar R, Bose RJ, Vanama J, Palaniyandi SS, Konishi T, Watanabe K, Thandavarayan RA (2017) Tiny molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy. Nutrition 34:47â54
Khamaneh AM, Alipour MR, Sheikhzadeh Hesari F, Ghadiri Soufi F (2015) A signature of microRNA-155 in the pathogenesis of diabetic complications. J Physiol Biochem 71:301â309
Kim HY, Kang KS, Yamabe N, Nagai R, Yokozawa T (2007) Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem 55:8491â8497
Kim YJ, Zhang D, Yang DC (2015) Biosynthesis and biotechnological production of ginsenosides. Biotechnol Adv 33:717â735
Kim JH, Pan JH, Cho HT, Kim YJ (2016a) Black ginseng extract counteracts streptozotocin-induced diabetes in mice. PLoS One 11:e0146843
Kim JS, Jang HJ, Kim SS, Oh MY, Kim HJ, Lee SY, Eom DW, Ham JY, Han DJ (2016b) Red ginseng administration before islet isolation attenuates apoptosis and improves islet function and transplant outcome in a syngeneic mouse marginal islet mass model. Transplant Proc 48:1258â1265
King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166:877â894
Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58:109â119
Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, Sommerhoff CP, Noonan DM, Nerlich AG, Fontana L, Bachmeier BE (2014) MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol 8:581â595
Ku CR, Lee HJ, Kim SK, Lee EY, Lee MK, Lee EJ (2012) Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic beta-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr J 59:103â109
Kudolo GB, Wang W, Elrod R, Barrientos J, Haase A, Blodgett J (2006a) Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects â a randomized double-blind placebo-controlled crossover study. Clin Nutr 25:123â134
Kudolo GB, Wang W, Javors M, Blodgett J (2006b) The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects â a double blind placebo-controlled, crossover study. Clin Nutr 25:606â616
Kumar S, Singh R, Vasudeva N, Sharma S (2012) Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovasc Diabetol 11:9
Kumar A, Ekavali CK, Mukherjee M, Pottabathini R, Dhull DK (2015) Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol 761:288â297
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G (2015) Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol 161:69â81
Lee CH, Kim JH (2014) A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 38:161â166
Li KK, Gong XJ (2015) A review on the medicinal potential of Panax ginseng saponins in diabetes mellitus. RSC Adv 5:47353â47366
Li J, Wang P, Zhu Y, Chen Z, Shi T, Lei W, Yu S (2015) Curcumin inhibits neuronal loss in the retina and elevates Ca(2)(+)/calmodulin-dependent protein kinase II activity in diabetic rats. J Ocul Pharmacol Ther 31:555â562
Lim S, Yoon JW, Kang SM, Choi SH, Cho BJ, Kim M, Park HS, Cho HJ, Shin H, Kim YB, Kim HS, Jang HC, Park KS (2011) EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 6:e20301
Liu Z, Wang LJ, Li X, Hu JN, Chen Y, Ruan CC, Sun GZ (2009) Hypoglycemic effects of malonyl-ginsenosides extracted from roots of Panax ginseng on streptozotocin-induced diabetic mice. Phytother Res 23:1426â1430
Lu Q, Zuo WZ, Ji XJ, Zhou YX, Liu YQ, Yao XQ, Zhou XY, Liu YW, Zhang F, Yin XX (2015) Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy. Phytomedicine 22:1071â1078
Ma W, Li J, Hu J, Cheng Y, Wang J, Zhang X, Xu M (2016) miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells. Chem Biol Interact 245:72â81
Majithiya JB, Balaraman R (2005) Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol 46:697â705
Mccowen KC, Smith RJ (2013) Diabetes mellitus: classification and chemical pathology A2 - caballero, Benjamin. Encyclopedia of human nutrition, 3rd edn. Academic Press, Waltham, pp 17â24
Meghana K, Sanjeev G, Ramesh B (2007) Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 577:183â191
Mohammadi A, Mansoori B, Baradaran B (2017) Regulation of miRNAs by herbal medicine: an emerging field in cancer therapies. Biomed Pharmacother 86:262â270
Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A (2016) Curcumin as a MicroRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol 171:1â38
Monami M, Luzzi C, Lamanna C, Chiasserini V, Addante F, Desideri CM, Masotti G, Marchionni N, Mannucci E (2006) Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin. Diabetes Metab Res Rev 22:477â482
Monami M, Dicembrini I, Mannucci E (2014) Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 24:689â697
Moon HK, Kim KS, Chung SK, Kim JK (2015) Effect of wild Korean ginseng (Panax ginseng) extract on blood glucose and serum lipid contents in rats with multiple low-dose streptozotocin-induced diabetes. Food Sci Biotechnol 24:1505â1511
Movahed A, Nabipour I, Lieben Louis X, Thandapilly SJ, Yu L, Kalantarhormozi M, Rekabpour SJ, Netticadan T (2013) Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid Based Complement Alternat Med 2013:851267
Mukhopadhyay P, Pacher P, Das DK (2011) MicroRNA signatures of resveratrol in the ischemic heart. Ann N Y Acad Sci 1215:109â116
Nakou ES, Mavrakis H, Vardas PE (2012) Are diabetic patients at increased risk of arrhythmias? Hell J Cardiol 53:335â339
Naseem M, Zaman MQ, Nazih H, Ouguerram K, Rabbani I, Zaneb H, Yaqoob T, Rehman HU, Michel J, Tahir SK, Yousaf MS, Majeed KA, Hussain MS (2016) The effects of Ginkgo Biloba leaf extract on metabolic disturbances associated to alloxan-induced diabetic rats. J Anim Plant Sci 26:627â635
Neerati P, Devde R, Gangi AK (2014) Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother Res 28:1796â1800
Oh MJ, Kim HJ, Park EY, Ha NH, Song MG, Choi SH, Chun BG, Kim DH (2017) The effect of Korean red ginseng extract on rosiglitazone-induced improvement of glucose regulation in diet-induced obese mice. J Ginseng Res 41:52â59
Palma HE, Wolkmer P, Gallio M, Correa MM, Schmatz R, Thome GR, Pereira LB, Castro VS, Pereira AB, Bueno A, De Oliveira LS, Rosolen D, Mann TR, De Cecco BS, Graca DL, Lopes ST, Mazzanti CM (2014) Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin. Mol Cell Biochem 386:199â210
Palsamy P, Subramanian S (2008) Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother 62:598â605
Pan ZW, Lu YJ, Yang BF (2010) MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol Sin 31:1â9
Pang B, Zhao LH, Zhou Q, Zhao TY, Wang H, Gu CJ, Tong XL (2015a) Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol 2015:905749
Pang XF, Zhang LH, Bai F, Wang NP, Shah AI, Garner R, Zhao ZQ (2015b) Dual ACE-inhibition and angiotensin II AT(1) receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart. Eur J Pharmacol 746:22â30
Park HJ, Kim DH, Park SJ, Kim JM, Ryu JH (2012) Ginseng in traditional herbal prescriptions. J Ginseng Res 36:225â241
Prasad S, Aggarwal BB (2011) Turmeric, the golden spice: from traditional medicine to modern medicine. In: IFF B, Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press/Taylor & Francis Llc., Boca Raton (FL), pp 263â288
Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Ghayour Mobarhan M, Kazemi Oskuee R (2016) The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed 6:567â577
Rashid K, Sil PC (2015) Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol Appl Pharmacol 282:297â310
Rawal S, Manning P, Katare R (2014) Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol 13:44
Ren M, Yang S, Li J, Hu Y, Ren Z, Ren S (2013) Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress. Endocrine 43:360â369
Rhee KJ, Lee CG, Kim SW, Gim DH, Kim HC, Jung BD (2015) Extract of Ginkgo Biloba ameliorates streptozotocin-induced type 1 diabetes mellitus and high-fat diet-induced type 2 diabetes mellitus in mice. Int J Med Sci 12:987â994
Saini AS, Taliyan R, Sharma PL (2014) Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats. Pharmacogn Mag 10:172â178
Schmatz R, Schetinger MR, Spanevello RM, Mazzanti CM, Stefanello N, Maldonado PA, Gutierres J, Correa Mde C, Girotto E, Moretto MB, Morsch VM (2009) Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Life Sci 84:345â350
Schmatz R, Perreira LB, Stefanello N, Mazzanti C, Spanevello R, Gutierres J, Bagatini M, Martins CC, Abdalla FH, Daci Da Silva Serres J, Zanini D, Vieira JM, Cardoso AM, Schetinger MR, Morsch VM (2012) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94:374â383
Schneider R, Welt K, Aust W, Kluge R, Loster H, Fitzl G (2010) Cardiovascular autonomic neuropathy in spontaneously diabetic rats with and without application of EGb 761. Histol Histopathol 25:1581â1590
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, Mcguire DK, Ray KK, Leiter LA, Raz I, SAVOR-TIMI 53 Steering Committee and Investigators (2013) Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369:1317â1326
Sekar D, Venugopal B, Sekar P, Ramalingam K (2016) Role of microRNA 21 in diabetes and associated/related diseases. Gene 582:14â18
Sen S, Chen S, Wu Y, Feng B, Lui EK, Chakrabarti S (2013) Preventive effects of north American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. Phytother Res 27:290â298
Seo YS, Shon MY, Kong R, Kang OH, Zhou T, Kim DY, Kwon DY (2016) Black ginseng extract exerts anti-hyperglycemic effect via modulation of glucose metabolism in liver and muscle. J Ethnopharmacol 190:231â240
Sethupathy P (2016) The promise and challenge of therapeutic MicroRNA silencing in diabetes and metabolic diseases. Curr Diab Rep 16:52
Shakibaei M, Harikumar KB, Aggarwal BB (2009) Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53:115â128
Shi Y, Wan X, Shao N, Ye R, Zhang N, Zhang Y (2016) Protective and antiangiopathy effects of ginsenoside re against diabetes mellitus via the activation of p38 MAPK, ERK1/2 and JNK signaling. Mol Med Rep 14:4849â4856
Siegel G, Ermilov E, Knes O, Rodriguez M (2014) Combined lowering of low grade systemic inflammation and insulin resistance in metabolic syndrome patients treated with Ginkgo biloba. Atherosclerosis 237:584â588
Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, Harima M, Thandavarayan RA, Suzuki K, Nagata M, Takagi R, Watanabe K (2012) Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Eur J Pharm Sci 47:604â614
Soleas GJ, Diamandis EP, Goldberg DM (1997) Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30:91â113
Spadiene A, Savickiene N, Jurgeviciene N, Zalinkevicius R, Norkus A, Ostrauskas R, Skesters A, Silova A, Rodovicius H, Francaite-Daugeliene M (2013) Effect of ginkgo extract on eye microcirculation in patients with diabetes. Cent Eur J Med 8:736â741
Stein SA, Lamos EM, Davis SN (2013) A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf 12:153â175
Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M (2010) Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 298:H833âH843
Suman RK, Borde MK, Mohanty IR, Maheshwari U, Deshmukh YA (2016) Myocardial salvaging effects of berberine in experimental diabetes co-existing with myocardial infarction. J Clin Diagn Res 10:FF13âFF18
Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7:464â473
Sun C, Chen Y, Li X, Tai G, Fan Y, Zhou Y (2014) Anti-hyperglycemic and anti-oxidative activities of ginseng polysaccharides in STZ-induced diabetic mice. Food Funct 5:845â848
Sun Y, Liu Y, Chen K (2016) Roles and mechanisms of ginsenoside in cardiovascular diseases: progress and perspectives. Sci China Life Sci 59:292â298
Suresh Babu P, Srinivasan K (1995) Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152:13â21
Suryanarayana P, Satyanarayana A, Balakrishna N, Kumar PU, Reddy GB (2007) Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. Med Sci Monit 13:BR286âBR292
Szablewski L (2014) Role of immune system in type 1 diabetes mellitus pathogenesis. Int Immunopharmacol 22:182â191
Szkudelski T, Szkudelska K (2015) Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta 1852:1145â1154
Takeda N (2010) Cardiac disturbances in diabetes mellitus. Pathophysiology 17:83â88
Takikawa M, Kurimoto Y, Tsuda T (2013) Curcumin stimulates glucagon-like peptide-1 secretion in GLUTag cells via Ca2+/calmodulin-dependent kinase II activation. Biochem Biophys Res Commun 435:165â170
Taliyan R, Sharma PL (2012) Protective effect and potential mechanism of Ginkgo biloba extract EGb 761 on STZ-induced neuropathic pain in rats. Phytother Res 26:1823â1829
Tang LQ, Wei W, Chen LM, Liu S (2006) Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108:109â115
Thazhath SS, Wu T, Bound MJ, Checklin HL, Standfield S, Jones KL, Horowitz M, Rayner CK (2016) Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am J Clin Nutr 103:66â70
Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N (2007) Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43:720â729
Timmers S, De Ligt M, Phielix E, Van De Weijer T, Hansen J, Moonen-Kornips E, Schaart G, Kunz I, Hesselink MK, Schrauwen-Hinderling VB, Schrauwen P (2016) Resveratrol as add-on therapy in subjects with well-controlled type 2 diabetes: a randomized controlled trial. Diabetes Care 39:2211â2217
Tome-Carneiro J, Larrosa M, Yanez-Gascon MJ, Davalos A, Gil-Zamorano J, Gonzalvez M, Garcia-Almagro FJ, Ruiz Ros JA, Tomas-Barberan FA, Espin JC, Garcia-Conesa MT (2013) One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res 72:69â82
Tosaki A, Pali T, Droy-Lefaix MT (1996) Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 39:1255â1262
Tsai HY, Huang PH, Lin FY, Chen JS, Lin SJ, Chen JW (2013) Ginkgo biloba extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways. Eur J Pharm Sci 48:803â811
Tsai CC, Chan P, Chen LJ, Chang CK, Liu Z, Lin JW (2014) Merit of ginseng in the treatment of heart failure in type 1-like diabetic rats. Biomed Res Int 2014:484161
Tsukita S, Yamada T, Takahashi K, Munakata Y, Hosaka S, Takahashi H, Gao J, Shirai Y, Kodama S, Asai Y, Sugisawa T, Chiba Y, Kaneko K, Uno K, Sawada S, Imai J, Katagiri H (2017) MicroRNAs 106b and 222 improve hyperglycemia in a mouse model of insulin-deficient diabetes via pancreatic β-cell proliferation. EBioMedicine 15:163â172
Voncannon JL, Jiao Y, Kim-Shapiro D, Varagic J (2014) Curcumin ameliorates cardiac dysfunction in the ovariectomized diabetic mRen2. Lewis rat by inhibiting renin angiotensin system. Hypertension 64:2
Wang LH, Yu CH, Fu Y, Li Q, Sun YQ (2011) Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model. Phytother Res 25:33â37
Wang LH, Li XL, Li Q, Fu Y, Yu HJ, Sun YQ, Zhang L, Shan HL (2012) Berberine alleviates ischemic arrhythmias via recovering depressed I(to) and I(Ca) currents in diabetic rats. Phytomedicine 19:206â210
Wang CW, Su SC, Huang SF, Huang YC, Chan FN, Kuo YH, Hung MW, Lin HC, Chang WL, Chang TC (2015) An essential role of cAMP response element binding protein in Ginsenoside Rg1-mediated inhibition of Na+/glucose Cotransporter 1 gene expression. Mol Pharmacol 88:1072â1083
Wang S, Ding L, Ji H, Xu Z, Liu Q, Zheng Y (2016) The role of p38 MAPK in the development of diabetic cardiomyopathy. Int J Mol Sci 17:1037
Wee JJ, Mee Park K, Chung AS (2011) Biological activities of ginseng and its application to human health. In: IFF B, Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press/Taylor & Francis Llc., Boca Raton (FL), pp 157â209
Wei S, Li W, Yu Y, Yao F, A L LX, Guan F, Zhang M, Chen L (2015) Ginsenoside compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: a study in vitro and in vivo. Life Sci 139:8â15
Whittington HJ, Babu GG, Mocanu MM, Yellon DM, Hausenloy DJ (2012) The diabetic heart: too sweet for its own good? Cardiol Res Pract 2012:845698
Wongcharoen W, Phrommintikul A (2009) The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133:145â151
Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM (2011) Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep 38:4327â4335
Wu YS, Chen YT, Bao YT, Li ZM, Zhou XJ, He JN, Dai SJ, Li CY (2016) Identification and verification of potential therapeutic target genes in berberine-treated Zucker diabetic fatty rats through bioinformatics analysis. PLoS One 11:e0166378
Xavier S, Sadanandan J, George N, Paulose CS (2012) Beta(2)-adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: antagonism by vitamin D(3) and curcumin. Eur J Pharmacol 687:14â20
Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J (2011) Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One 6:e16556
Xianghua F, Weili W, Yangmei Y, Xuechao W, Yanbo W, Weize F, Yunfa J, Guozhen H (2010) e0413 the adverse effects of glibenclamide on myocardial perfusion in patients with acute myocardial infarction and type 2 diabetes mellitus. Heart 96:A127âA128
Xiao J, Sheng X, Zhang X, Guo M, Ji X (2016) Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Des Devel Ther 10:1267â1277
Yan X, Xue J, Wu H, Wang S, Liu Y, Zheng S, Zhang C, Yang C (2015) Ginsenoside-Rb1 protects hypoxic- and ischemic-damaged cardiomyocytes by regulating expression of miRNAs. Evid Based Complement Alternat Med 2015:171306
Yan R, Shan H, Lin L, Zhang M, Diao JY, Li Q, Liu X, Wei J (2016) Chronic resveratrol treatment improves cardiac function in a rat model of diabetic cardiomyopathy via attenuation of mitochondrial injury and myocardial apoptosis. Int J Clin Exp Med 9:21156â21167
Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486â491
Yang H, Xu W, Zhou Z, Liu J, Li X, Chen L, Weng J, Yu Z (2015) Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. Exp Clin Endocrinol Diabetes 123:360â367
Yao J, Kong W, Jiang J (2015a) Learning from berberine: treating chronic diseases through multiple targets. Sci China Life Sci 58:854â859
Yao L, Wan J, Li H, Ding J, Wang Y, Wang X, Li M (2015b) Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. Reprod Biol Endocrinol 13:118
Yazgan UC, Tasdemir E, Bilgin HM, Deniz Obay B, Sermet A, Elbey B (2015) Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes. Arch Physiol Biochem 121:157â161
Yildirim SS, Akman D, Catalucci D, Turan B (2013) Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys 67:1397â1408
Yin J, Xing H, Ye J (2008) Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57:712â717
Yonamine CY, Pinheiro-Machado E, Michalani ML, Freitas HS, Okamoto MM, Correa-Giannella ML, Machado UF (2016) Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory. Nutr Metab (Lond) 13:44
Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D, Guo S, Ming Z, Liu C (2012) Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One 7:e52013
Yu W, Zha W, Ke Z, Min Q, Li C, Sun H, Liu C (2016) Curcumin protects neonatal rat cardiomyocytes against high glucose-induced apoptosis via PI3K/Akt signalling pathway. J Diabetes Res 2016:4158591
Yuan HD, Chung SH (2010) Protective effects of fermented ginseng on streptozotocin-induced pancreatic beta-cell damage through inhibition of NF-kappa B. Int J Mol Med 25:53â58
Yuan HD, Kim JT, Kim SH, Chung SH (2012) Ginseng and diabetes: the evidences from in vitro, animal and human studies. J Ginseng Res 36:27â39
Zhang XF, Liang B, Liang ZF, Lin J (2008) Effects of Gingko biloba leaf extract on learning, memory, and hippocampal amyloid precursor protein mRNA expressions in diabetic rats. Neural Regen Res 3:29â32
Zhang H, Morgan B, Potter BJ, Ma L, Dellsperger KC, Ungvari Z, Zhang C (2010a) Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol 299:H985âH994
Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN, Kong WJ, Jiang JD (2010b) Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59:285â292
Zheng B, Yang L, Wen C, Huang X, Xu C, Lee KH, Xu J (2016) Curcumin analog L3 alleviates diabetic atherosclerosis by multiple effects. Eur J Pharmacol 775:22â34
Zhi Y, Pan J, Shen W, He P, Zheng J, Zhou X, Lu G, Chen Z, Zhou Z (2016) Ginkgolide B inhibits human bladder cancer cell migration and invasion through MicroRNA-223-3p. Cell Physiol Biochem 39:1787â1794
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Âİ 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kaya, S.T., Guven, C., Taskin, E. (2019). Herbal Medicine in Diabetes Mellitus with Cardiovascular Diseases. In: Ozturk, M., Hakeem, K. (eds) Plant and Human Health, Volume 3. Springer, Cham. https://doi.org/10.1007/978-3-030-04408-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-04408-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04407-7
Online ISBN: 978-3-030-04408-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)